Arcutis Biotherapeutics Executive Disposes of $192,000 in Common Stock
Masaru Matsuda, who serves as the Executive Vice President and Chief Legal Officer at Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT), has completed the sale of common stock totaling $192,415. These transactions took place on May 4, 2026, involving two distinct types of sales that reflect different financial motivations ranging from pre-planned divest…